Study finds restrictive clinical trial criteria excludes Lyme disease patients
Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.
ESG
Percheron plans to broaden pipeline following avicursen disappointment
Xgene’s non-opioid analgesic reduces pain in Phase IIb trial
Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
APAC leading in Parkinson’s disease clinical trials
CEPI funds safety project for vaccines in Africa
Generative AI has ‘potential to revolutionise clinical development’
